Phlebotics
1 known investors
Phlebot is developing automated blood sampling (ABS) technology aimed at applying automation to blood collection, targeting intensive care medicine and longer-term research. Its stated goal is to reduce patient pain and labor while improving safety, accuracy, and reliability of blood collection; the technology is not yet an approved medical device for human use.
Investors Β· 1
Frequently asked questions
- What does Phlebotics do?
- Phlebot is developing automated blood sampling (ABS) technology aimed at applying automation to blood collection, targeting intensive care medicine and longer-term research. Its stated goal is to reduce patient pain and labor while improving safety, accuracy, and reliability of blood collection; the technology is not yet an approved medical device for human use.
- Who are Phlebotics's investors?
- Phlebotics's investors include Elevate Ventures.